Unraveling the Enigma of Melanoma Brain Metastasis: New Horizons in Mechanisms, Diagnosis, and Therapy
Preprint
- 7 January 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Melanoma, a highly aggressive and metastatic cancer, poses significant challenges due to its propensity to spread to distant organs, with brain metastasis representing a particularly devastating complication. This review synthesizes recent advances in understanding the molecular, cellular, and microenvironmental mechanisms driving melanoma metastasis, with a specific emphasis on brain metastasis. We explore the unique challenges of brain metastasis, including blood-brain barrier penetration, brain-specific microenvironment interactions, and genomic distinctions. Advances in diagnostic tools, such as imaging and liquid biopsies, are discussed alongside current and emerging therapeutic strategies, including novel small molecules, immunotherapies, and combination approaches tailored for brain metastases. The review also highlights the immunological landscape of the brain, translational models, and multidisciplinary clinical management strategies. Finally, we identify critical research gaps, including the need for brain metastasis-specific clinical trials, AI-driven predictive models, and preventive strategies, to guide future efforts in improving outcomes for patients with melanoma brain metastasis.Keywords
All Related Versions
This publication has 218 references indexed in Scilit:
- AI‐Enhanced Predictive Imaging in Precision Medicine: Advancing Diagnostic Accuracy and Personalized TreatmentiRADIOLOGY, 2025
- Extracellular RNA communication: A decade of NIH common fund support illuminates exRNA biologyJournal of Extracellular Vesicles, 2025
- Melanoma Treatments and Mortality Rate Trends in the US, 1975 to 2019JAMA Network Open, 2022
- Role of radiation oncology in modern multidisciplinary cancer treatmentMolecular Oncology, 2020
- Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapiesCancer, 2017
- Epithelial-mesenchymal plasticity in circulating tumor cellsJournal of Molecular Medicine, 2016
- Can animal data predict human outcome? Problems and pitfalls of translational animal researchEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- NRAS mutation status is an independent prognostic factor in metastatic melanomaCancer, 2011
- Prognostic factors for survival in melanoma patients with brain metastasesCancer, 2010
- Targeting cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4)Cancer, 2007